Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome

American Journal of Clinical Pathology

Volumn 130, Issue 6, 2008, Pages 957-962

  Czuchlewski, David R ^a   Csernus, Balazs ^a   Bubman, Darya ^a   Hyjek, Elizabeth ^a   Martin, Peter ^a   Chadburn, Amy ^a   Knowles, Daniel M ^a   Cesarman, Ethel ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Ceramide; Follicular lymphoma variant translocation 1 gene; FVT1; Lymphoma; Sphingolipids

Indexed keywords

CERAMIDE; SPHINGOLIPID;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; FOLLICULAR LYMPHOMA VARIANT TRANSLOCATION 1 GENE; GENE; GENE EXPRESSION; GENE TRANSLOCATION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ALCOHOL OXIDOREDUCTASES; CERAMIDES; GENE EXPRESSION REGULATION, NEOPLASTIC; GERMINAL CENTER; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; PALATINE TONSIL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58049194284     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP12HIRWSRQLAN     Document Type: Article

References (28)

1. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4:604-616.
2. Ruvolo PP. Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia. 2001;15:1153-1160.
3. Osawa Y, Uchinami H, Bielawski J, et al. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factoralpha. J Biol Chem. 2005;280:27879-27887.
4. Quintans J, Kilkus J, McShan CL, et al. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem Biophys Res Commun. 1994;202:710-714.
5. Vit JP, Rosselli F. Role of the ceramide-signaling pathways in ionizing radiation-induced apoptosis. Oncogene. 2003;22:8645-8652.
6. Pettus BJ, Chalfant CE, Hannun YA. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta. 2002;1585:114-125.
7. Maceyka M, Payne SG, Milstien S, et al. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochem Biophys Acta. 2002;1585:193-201.
8. Pettus BJ, Bielawski J, Porcelli AM, et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. FASEB J. 2003;17:1411-1121.
9. Taha TA, Hannun YA, Obeid LM. Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol. 2006;39:113-131.
10. Bayerl MG, Abou-Elella A, Bruggeman RD, et al. Sphingosine kinase 1 protein and mRNA is highly expressed in B-cell NHL and is a potential target for pharmacological inhibition. Mod Pathol. 2007;20:232A-267A.
11. Sobue S, Iwasaki T, Sugisaki C, et al. Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes. Leukemia. 2006;20:2042-2046.
12. Kihara A, Igarashi Y. FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an active site that faces the cytosolic side of the endoplasmic reticulum membrane. J Biol Chem. 2004;279:49243-49250.
13. Fan W, Bubman D, Chadburn A, et al. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol. 2005;79:1244-1251.
14. Rimokh R, Gadoux M, Bertheas MF, et al. FVT-1, a novel human transcription unit affected by variant translocation t(2;18)(p11;q21) of follicular lymphoma. Blood. 1993;81:136-142.
15. Lee KE. Bayesian Models for DNA Microarray Data Analysis [dissertation]. College Station: Texas A&M University; 2004:41-50. http://txspace.tamu.edu/handle/1969.1/2465. Accessed October 1, 2008.
16. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-282.
17. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
18. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.
19. Chen YB, Rahemtullah A, Hochberg E. Primary effusion lymphoma. Oncologist. 2007;12:569-576.
20. Boulanger E, Gerard L, Gabarre J, et al. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol. 2005;19:4372-4380.
21. Perry DK. Serine palmitoyltransferase: role in apoptotic de novo ceramide synthesis and other stress responses. Biochim Biophys Acta. 2002;1585:146-152.
22. Kalen A, Borchardt RA, Bell RM. Elevated ceramide levels in GH4C1 cells treated with retinoic acid. Biochim Biophys Acta. 1992;1125:90-96.
23. Bose R, Verheij M, Haimovitz-Friedman A, et al. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell. 1995;82:405-414.
24. Garzotto M, White-Jones M, Jiang Y, et al. 12-O-tetradecanoylphorbol-13- acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res. 1998;58:2260-2264.
25. Reynolds CP, Maurer BJ, Kolesnick RN. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett. 2004;206:169-180.
26. Radin NS. Killing tumors by ceramide-induced apoptosis: a critique of available drugs. Biochem J. 2003;371:243-256.
27. Mansoor M, Melendez AJ. Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine. Rev Recent Clin Trials. 2008;3:62-69.
28. Liu Q, Zhao X, Frissora F, et al. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood. 2008;111:275-284.